Eli Lilly reported dysesthesia was "generally mild" and "rarely led to discontinuation." TRIUMPH-1 the larger general obesity trial with 2,339 patients at 80 weeks confirmed dysesthesia at 12.5% on the 12mg dose, substantially lower than TRIUMPH-4's 20.9%
Even when lab values appear normal on medication, many patients still struggle with: Slowed metabolism Insulin resistance Increased fat storage Chronic inflammation Fatigue that limits physical activity These factors create a perfect storm where calorie restriction backfires, muscle mass declines, and weight loss stalls
2A, B) 13
A small needle is then used to administer the weight-loss medication, as with any other injection
While we do not offer GLP-1 drugs for weight loss, our experienced physicians are happy to help you understand the risks and benefits of these drugs or refer you to a specialist if necessary
Virtual consultations may also be available for eligible patients who prefer the privacy and convenience of discussing care from home